<SUP>18</SUP>F-FDG PET/CT Unveils Coexistent Myelomatous Hepatosplenic and Thyroid Cartilage Involvement
CLINICAL NUCLEAR MEDICINE, vol.49, no.9, pp.897-898, 2024 (SCI-Expanded, Scopus)
- Publication Type: Article / Editorial Material
- Volume: 49 Issue: 9
- Publication Date: 2024
- Doi Number: 10.1097/rlu.0000000000005326
- Journal Name: CLINICAL NUCLEAR MEDICINE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
- Page Numbers: pp.897-898
- Hacettepe University Affiliated: Yes
Abstract
Extramedullary myelomatous disease is an aggressive condition where clonal plasma cells proliferate outside the bone marrow, allowing independent survival. This state is generally associated with negative outcomes. A 65-year-old woman presented with progressive bilateral hypochondrial pain, was initially misattributed to an inflammatory etiology, and was consequently managed with corticosteroid therapy. A bone marrow biopsy was offered after further deterioration confirming plasma cell myeloma. Afterward, F-18-FDG PET/CT revealed medullary and extramedullary hepatosplenic and thyroid cartilage involvement, concluding an overall picture of an atypical and extensive extramedullary myelomatous disease.